3 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow NAFLD: new trials by email Literature Review of NAFLD trials Research Report on NAFLD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH) Saroglitazar, Vitamin E, Combination drug - NAFLD | Phase 3 | Unknown | Asian Institute of Gastroenterology, India | 250 | 2021-01-31 | 2021-01-26 |
| The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation and Oxidative Stress Parameters and Faecal Microbiota in Patients With Depression Depending on Metabolic Syndrome Comorbidity Lactobacillus helveticus Rosell®-52, Bifidobacterium longum Rosell®-175, placebo - Depressive Disorder, Depression | Phase 3 | Unknown | Medical University of Lodz | 200 | 2020-12-17 | 2021-02-16 |
| Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment Specialized product for medical nutrition (SPP-1), individualized diet - NAFLD, NASH - Nonalcoholic Steatohepatitis | Phase 2 / Phase 3 | Unknown | Russian Academy of Medical Sciences | 45 | 2020-03-20 | 2021-02-03 |
Non-alcoholic Fatty Liver Disease (3) · Anxiety Disorders (1) · Depression (1) · Depressive Disorder (1) · Fatty Liver (1) · Inflammation (1) · Metabolic Syndrome (1)
Digestive System Diseases (3) · Liver Diseases (3) · Fatty Liver (2) · Behavior (1) · Behavioral Symptoms (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Insulin Resistance (1) · Mental Disorders (1) · Metabolic Diseases (1) · Mood Disorders (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Drug Combinations (1) · Vitamin E (1) · saroglitazar (1)
Asian Institute of Gastroenterology, India (1) · Medical University of Lodz (1) · Russian Academy of Medical Sciences (1)
India (1) · Poland (1) · Russia (1)
PMID 33804999, PMID 35596633, PMID 38732635, PMID 39089652, PMID 39683419, PMID 40520599, PMID 41177800, PMID 41484701